Industry News

Indoco Remedies Goa Plant reinstates full GMP status

  • Posted on: 13 September 2019
  • By: PharmaTutor News

Indoco Remedies announced that the Inspection Action Group (IAG) of the United Kingdom has confirmed that the GMP status for its Goa Plant I has been fully re-instated by UK regulator, The Medicines and Healthcare Products Regulatory Agency of the United Kingdom (UK-MHRA). This is an outcome of the full GMP inspection conducted by the MHRAfrom May 21 - 23, 2019.

Biocon partnered with CMS for supply of three generic formulation products in China

  • Posted on: 13 September 2019
  • By: PharmaTutor News

Biocon Ltd announced that it has signed a License and Supply Agreement with a subsidiary of China Medical System Holdings Ltd. (CMS) for three Generic Formulation products in Greater China. 

Biocon Ltd announced that it has signed a License and Supply Agreement with a subsidiary of China Medical System Holdings Ltd. (CMS) for three Generic Formulation products in Greater China.

Labeling Error from Pharmaceutical company lead to develop werewolf syndrome in Children

  • Posted on: 4 September 2019
  • By: admin

Almost 17 children were affected with hypertrichosis outbreak or werewolf syndrome due to labeling error by pharmaceutical company in Spain. The company named Farm-Química Sur accidentally sold minoxidil which is most commonly used to treat alopecia as omeprazole a drug used to treat heartburn and acid reflux.

New measures to avoid potentially fatal dosing errors with methotrexate for inflammatory diseases

  • Posted on: 28 August 2019
  • By: Shalini.Sharma

EMA has recommended new measures to prevent serious and potentially fatal errors with the dosing of methotrexate for treating inflammatory diseases such as rheumatoid arthritis, psoriasis and Crohn’s disease. The recommendations result from a review of reports that patients are using methotrexate incorrectly despite previous measures to prevent errors.

Vaccines Market value to hit $72.5 billion by 2025 : Global Market Insights

  • Posted on: 16 August 2019
  • By: PharmaTutor News

Global Market Insights, Inc., announces a research report on ‘Vaccines Market Trends and Forecast 2019-2025’. The report covers an extensive summary of the age group, technology, disease, regional, and competitive landscapes. Global Vaccines industry revenue is set to exceed $72.5 billion by 2025.

Global vaccines market size has expanded rapidly owing to increased prevalence of chronic disorders and a rising population base. Improved healthcare systems and better awareness throughout emerging economies has strengthened the demand for critical therapies, while higher disposable incomes and favorable health insurance policies have enabled access to advanced treatment options.

Pharma companies received notices for introducing drugs without prior approval of the NPPA

  • Posted on: 29 July 2019
  • By: PharmaTutor News

Pharmaceutical Companies which introduced 22 drugs without prior approval of the National Pharmaceutical Pricing Authority (NPPA) have been issued notices by Government. The NPPA regularly takes action against such companies as per provisions of the Drugs (Prices Control) Order, 2013 (DPCO) which has been issued under the Essential Commodities Act, 1955.

InvaGen Pharmaceuticals received final approval for generic version of Pfizer’s Lyrica®

  • Posted on: 23 July 2019
  • By: PharmaTutor News

InvaGen Pharmaceuticals, Inc. a wholly-owned subsidiary of the leading global pharmaceutical company Cipla Limited announced the receipt of final approval for its Abbreviated New Drug Application (ANDA) for Pregabalin Capsules, 25mg, 50mg, 75mg, 100mg, 150mg, 200mg, 225mg and 300mg from the United States Food and Drug Administration (US FDA).

Pages